4 articles
FDA Approves mFlusiva, the First mRNA Flu Vaccine, for Adults 50 and Older The United States Food and Drug Administration (FDA) has approved mFlusiva (mRNA-1010),...
A New Era for One of the Deadliest Cancers The U.S. Food and Drug Administration (FDA) has approved daraxonrasib (brand name Rasonque) — a first-in-class...
The U.S. Food and Drug Administration (FDA) has approved mFLUSIVA, the first mRNA-based influenza vaccine, for adults aged 50 and older — just in time...